Sipai Health Technology Co's quarterly market cap
declined
from Dec. 2022 (HK$14,253 Mil) to Jun. 2023 (HK$5,753 Mil) and
declined
from Jun. 2023 (HK$5,753 Mil) to Dec. 2023 (HK$5,254 Mil).
Sipai Health Technology Co's annual market cap
increased
from Dec. 2021 (HK$0 Mil) to Dec. 2022 (HK$14,253 Mil) but then
declined
from Dec. 2022 (HK$14,253 Mil) to Dec. 2023 (HK$5,254 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Sipai Health Technology Co's Enterprise Value for Today is HK$3,374 Mil.
Sipai Health Technology Co Market Cap Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Sipai Health Technology Co Market Cap Chart
Sipai Health Technology Co Annual Data
Trend
Dec21
Dec22
Dec23
Market Cap
-
14,253.31
5,254.35
Sipai Health Technology Co Semi-Annual Data
Dec21
Jun22
Dec22
Jun23
Dec23
Market Cap
-
-
14,253.31
5,753.21
5,254.35
Competitive Comparison of Sipai Health Technology Co's Market Cap
For the Medical Distribution subindustry, Sipai Health Technology Co's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sipai Health Technology Co's Market Cap Distribution in the Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Sipai Health Technology Co's Market Cap distribution charts can be found below:
* The bar in red indicates where Sipai Health Technology Co's Market Cap falls into.
Sipai Health Technology Co Market Cap Calculation
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sipai Health Technology Co (HKSE:00314) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Sipai Health Technology Co Market Cap Related Terms
Thank you for viewing the detailed overview of Sipai Health Technology Co's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.
Sipai Health Technology Co (HKSE:00314) Business Description
Sipai Health Technology Co Ltd is a medical technology and health management company in China. It has three reportable operating segments: Specialty Pharmacy Business - operation and distribution of specialty pharmacy stores and pharmaceutical products; Physician Research Assistance Business - offering pharmaceutical companies and other clinical trial institutions site management organization services; Health Insurance Services Business - rendering insurance brokerage services to insurance companies. The company generates key revenue from Specialty Pharmacy Business. Almost all of the company's revenues were derived from operations in the PRC.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
HKSE:00314 has been successfully added to your